SLA and immune system disorder: Czaja et al25 suggested that HLA DR3 was associated with early age onset and treatment failure, whereas HLA DR4 was associated with concurrent other immune diseases and remission during immunosuppressive therapy.26 Our analysis showed that patients with anti-SLA have HLA DR3 more frequently than patients without.